Sternberg CN - Search Results

1

Abiraterone and increased survival in metastatic prostate cancer.

de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, Cheng T, Patterson H, Hainsworth JD, Ryan CJ, Sternberg CN, Ellard SL, Fléchon A, Saleh M, Scholz M, Efstathiou E, Zivi A, Bianchini D, Loriot Y, Chieffo N, Kheoh T, Haqq CM, Scher HI; COU-AA-301 Investigators. de Bono JS, et al. Among authors: sternberg cn. N Engl J Med. 2011 May 26;364(21):1995-2005. doi: 10.1056/NEJMoa1014618. N Engl J Med. 2011. PMID: 21612468 Free PMC article. Clinical Trial.

2

Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors.

Seidman AD, Scher HI, Heinemann MH, Bajorin DF, Sternberg CN, Dershaw DD, Silverberg M, Bosl GJ. Seidman AD, et al. Among authors: sternberg cn. Cancer. 1991 Dec 15;68(12):2561-5. doi: 10.1002/1097-0142(19911215)68:12<2561::aid-cncr2820681205>3.0.co;2-g. Cancer. 1991. PMID: 1933802 Clinical Trial.

3

Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy.

Geller NL, Sternberg CN, Penenberg D, Scher H, Yagoda A. Geller NL, et al. Among authors: sternberg cn. Cancer. 1991 Mar 15;67(6):1525-31. doi: 10.1002/1097-0142(19910315)67:6<1525::aid-cncr2820670611>3.0.co;2-8. Cancer. 1991. PMID: 2001540

4

Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.

Sternberg CN, Yagoda A, Scher HI. Sternberg CN, et al. Prog Clin Biol Res. 1988;277:45-51. Prog Clin Biol Res. 1988. PMID: 3054909 Clinical Trial. No abstract available.

5

Current status of chemotherapy for urothelial tract tumors.

Sternberg CN, Scher HI. Sternberg CN, et al. Oncology (Williston Park). 1987 Jul;1(5):41-50, 60. Oncology (Williston Park). 1987. PMID: 3079483 Review.

6

M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.

Sternberg CN, Yagoda A, Scher HI, Whitmore WF Jr, Herr HW, Morse MJ, Sogani PC, Watson RC, Hollander PS, Fair WR. Sternberg CN, et al. Prog Clin Biol Res. 1988;260:481-5. Prog Clin Biol Res. 1988. PMID: 3283768 Clinical Trial. No abstract available.

7

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani PC, Vaughan ED Jr, Bander N, Weiselberg LR, et al. Sternberg CN, et al. J Urol. 1988 Mar;139(3):461-9. doi: 10.1016/s0022-5347(17)42494-3. J Urol. 1988. PMID: 3343727

8

Advances in the treatment of urothelial tract tumors.

Sternberg CN, Scher HI. Sternberg CN, et al. Urol Clin North Am. 1987 May;14(2):373-87. Urol Clin North Am. 1987. PMID: 3554694 Review.

9

Chemotherapy of urologic malignancies.

Scher HI, Sternberg CN. Scher HI, et al. Among authors: sternberg cn. Semin Urol. 1985 Nov;3(4):239-80. Semin Urol. 1985. PMID: 3916569 Review. No abstract available.

10

Treatment of brain metastases from bladder cancer.

Rosenstein M, Wallner K, Scher H, Sternberg CN. Rosenstein M, et al. Among authors: sternberg cn. J Urol. 1993 Mar;149(3):480-3. doi: 10.1016/s0022-5347(17)36123-2. J Urol. 1993. PMID: 8437250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

445 results

Search Page